Board of Scientific Counselors, Office of Public Health Preparedness and Response, (BSC, OPHPR), 50374 [2018-21702]

Download as PDF 50374 Federal Register / Vol. 83, No. 194 / Friday, October 5, 2018 / Notices daltland on DSKBBV9HB2PROD with NOTICES advertising, promotion, offering for sale, or sale of any product or service, from making any misrepresentation about the existence, contents, validity, results, conclusions, or interpretations of any test, study, or other research, or that any product or service is scientifically or clinically proven to produce any benefit. • Part V of the order requires that respondents, with regard to any human clinical test or study upon which they rely to substantiate any claim covered by the order, must preserve all underlying data and documents generally accepted by experts in the field as relevant to an assessment of the test. • Part VI of the order provides that nothing in the order prohibits respondents from making a representation for any drug that is approved in labeling for such drug under any tentative final or final monograph promulgated by the Food and Drug Administration, or under any new drug application approved by the FDA. Parts VII through XI are reporting and compliance provisions. Part VII mandates that respondents acknowledge receipt of the order and, for 10 years, distribute the order to certain employees and agents and secure acknowledgments from recipients of the order. Part VIII requires that respondents submit compliance reports to the FTC one year after the order’s issuance and submit additional reports when certain events occur. Part IX requires that, for 10 years, respondents create certain records and retain them for at least 5 years. Part X provides for the FTC’s continued compliance monitoring of respondents’ activity during the order’s effective dates. Part XI is a provision ‘‘sunsetting’’ the order after 20 years, with certain exceptions. The purpose of this analysis is to facilitate public comment on the proposed order. It is not intended to constitute an official interpretation of the complaint or order, or to modify in any way the order’s terms. By direction of the Commission. Donald S. Clark, Secretary. [FR Doc. 2018–21749 Filed 10–4–18; 8:45 am] BILLING CODE 6750–01–P VerDate Sep<11>2014 17:11 Oct 04, 2018 Jkt 247001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, Office of Public Health Preparedness and Response, (BSC, OPHPR) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, Office of Public Health Preparedness and Response, (BSC, OPHPR). This meeting is open to the public, limited only by the space available. The meeting room accommodates up to 80 people. Public participants should pre-register for the meeting as described below. Members of the public that wish to attend this meeting in person should pre-register by submitting the following information by email, facsimile, or phone (see contact person for more information) no later than 12:00 noon (EDT) on Wednesday, October 22, 2018: • Full Name • Organizational Affiliation • Complete Mailing Address • Citizenship • Phone Number or Email Address The public is also welcome to listen to the meeting via Adobe Connect. Preregistration is required by clicking the links below. WEB ID: October 29, 2018 (1500 Seats) https://adobeconnect.cdc.gov/ e7gc21b4wp1/event/registration.html. WEB ID: October 30, 2018 (1500 Seats) https://adobeconnect.cdc.gov/ e5j7o9ulmi8/event/registration.html. Dial in number: 888–603–9747; Participant code: 3564724 (100 Seats). DATES: The meeting will be held on October 29, 2018, 10:00 a.m.–to 5:00 p.m., EDT and October 30, 2018, 8:30 a.m.–3:30 p.m., EDT. ADDRESSES: Centers for Disease Control and Prevention (CDC), Global Communications Center, Building 19, Auditorium B3, 1600 Clifton Road NE, Atlanta, Georgia 30329–4027. FOR FURTHER INFORMATION CONTACT: Dometa Ouisley, Office of Science and Public Health Practice, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop D–44, Atlanta, Georgia 30329–4027, Telephone: (404) 639–7450; Fax: (404) 471–8772; Email: OPHPR.BSC.Questions@cdc.gov. SUMMARY: PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 SUPPLEMENTARY INFORMATION: Purpose: This Board is charged with providing advice and guidance to the Secretary, Department of Health and Human Services (HHS), the Assistant Secretary for Health (ASH), the Director, Centers for Disease Control and Prevention (CDC), and the Director, Office of Public Health Preparedness and Response (OPHPR), concerning strategies and goals for the programs and research within OPHPR, monitoring the overall strategic direction and focus of the OPHPR Divisions and Offices, and administration and oversight of peer review for OPHPR scientific programs. For additional information about the Board, please visit: http:// www.cdc.gov/phpr/science/ counselors.htm. Matters to be Considered: The agenda for day one of the meeting will include discussions that will cover briefings and BSC deliberation on the following topics: Interval updates from the OPHPR Director and OPHPR Divisions and Offices; Presentation on Private Sector and PH Emergency Preparedness & Response Collaboration; and updates from the Biological Agent Containment working group. Day two of the meeting will cover briefings and BSC deliberation on the following topics: Preparedness updates from Liaison representatives; CDC’s Public Health Data Strategy and Data Preparedness initiatives; and updates on Pandemic Flu Activities and Planning Updates. Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2018–21702 Filed 10–4–18; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Statement of Organization, Functions, and Delegations of Authority Part C (Centers for Disease Control and Prevention) of the Statement of Organization, Functions, and Delegations of Authority of the E:\FR\FM\05OCN1.SGM 05OCN1

Agencies

[Federal Register Volume 83, Number 194 (Friday, October 5, 2018)]
[Notices]
[Page 50374]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21702]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Office of Public Health 
Preparedness and Response, (BSC, OPHPR)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors, 
Office of Public Health Preparedness and Response, (BSC, OPHPR). This 
meeting is open to the public, limited only by the space available. The 
meeting room accommodates up to 80 people. Public participants should 
pre-register for the meeting as described below. Members of the public 
that wish to attend this meeting in person should pre-register by 
submitting the following information by email, facsimile, or phone (see 
contact person for more information) no later than 12:00 noon (EDT) on 
Wednesday, October 22, 2018:

 Full Name
 Organizational Affiliation
 Complete Mailing Address
 Citizenship
 Phone Number or Email Address

    The public is also welcome to listen to the meeting via Adobe 
Connect. Pre-registration is required by clicking the links below.
    WEB ID: October 29, 2018 (1500 Seats) https://adobeconnect.cdc.gov/e7gc21b4wp1/event/registration.html.
    WEB ID: October 30, 2018 (1500 Seats) https://adobeconnect.cdc.gov/e5j7o9ulmi8/event/registration.html.
    Dial in number: 888-603-9747; Participant code: 3564724 (100 
Seats).

DATES: The meeting will be held on October 29, 2018, 10:00 a.m.-to 5:00 
p.m., EDT and October 30, 2018, 8:30 a.m.-3:30 p.m., EDT.

ADDRESSES: Centers for Disease Control and Prevention (CDC), Global 
Communications Center, Building 19, Auditorium B3, 1600 Clifton Road 
NE, Atlanta, Georgia 30329-4027.

FOR FURTHER INFORMATION CONTACT: Dometa Ouisley, Office of Science and 
Public Health Practice, Centers for Disease Control and Prevention, 
1600 Clifton Road NE, Mailstop D-44, Atlanta, Georgia 30329-4027, 
Telephone: (404) 639-7450; Fax: (404) 471-8772; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: This Board is charged with providing advice and guidance 
to the Secretary, Department of Health and Human Services (HHS), the 
Assistant Secretary for Health (ASH), the Director, Centers for Disease 
Control and Prevention (CDC), and the Director, Office of Public Health 
Preparedness and Response (OPHPR), concerning strategies and goals for 
the programs and research within OPHPR, monitoring the overall 
strategic direction and focus of the OPHPR Divisions and Offices, and 
administration and oversight of peer review for OPHPR scientific 
programs. For additional information about the Board, please visit: 
http://www.cdc.gov/phpr/science/counselors.htm.
    Matters to be Considered: The agenda for day one of the meeting 
will include discussions that will cover briefings and BSC deliberation 
on the following topics: Interval updates from the OPHPR Director and 
OPHPR Divisions and Offices; Presentation on Private Sector and PH 
Emergency Preparedness & Response Collaboration; and updates from the 
Biological Agent Containment working group.
    Day two of the meeting will cover briefings and BSC deliberation on 
the following topics: Preparedness updates from Liaison 
representatives; CDC's Public Health Data Strategy and Data 
Preparedness initiatives; and updates on Pandemic Flu Activities and 
Planning Updates. Agenda items are subject to change as priorities 
dictate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-21702 Filed 10-4-18; 8:45 am]
 BILLING CODE 4163-19-P